Drug shortage
Lisdexamfetamine Dimesylate Capsule · Apotex Corp.
FDA drug shortage · Current · updated Mar 27, 2025
Key facts
| Generic name | Lisdexamfetamine Dimesylate Capsule |
|---|---|
| Proprietary name | Lisdexamfetamine Dimesylate |
| Company | Apotex Corp. |
| Presentation | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) |
| Dosage form | Capsule |
| Strength | 20 mg |
| Status | Current |
| Therapeutic category | Psychiatry |
| Package NDCs | 60505-4740-1 |
| First posted | Nov 1, 2023 |
| Last updated | Mar 27, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: